Ignite Creation Date:
2024-05-06 @ 9:40 AM
Last Modification Date:
2024-10-26 @ 12:18 PM
Study NCT ID:
NCT03045029
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-08-04
First Post:
2017-02-02
Brief Title:
ADAPT - A Patient Registry of the Real-world Use of Orenitram
Sponsor:
Organization:
United Therapeutics
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
True
Target Duration:
78 Weeks
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
SAMPLES_WITH_DNA
Bio Spec Description:
1 Optional evaluation of biomarkers
2 Optional evaluation of pharmacogenomics
Enrollment Count:
300
Enrollment Type:
ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Cohort |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 39428 |
Who Masked List: